Short Interest in PainReform Ltd. (NASDAQ:PRFX) Increases By 504.3%

PainReform Ltd. (NASDAQ:PRFX) was the recipient of a large increase in short interest in March. As of March 15th, there was short interest totalling 13,900 shares, an increase of 504.3% from the February 29th total of 2,300 shares. Based on an average trading volume of 23,400 shares, the short-interest ratio is currently 0.6 days. Approximately 1.0% of the company’s stock are sold short.

PainReform Stock Up 2.2 %

Shares of PRFX traded up $0.04 during midday trading on Thursday, reaching $1.82. 2,665 shares of the stock were exchanged, compared to its average volume of 20,413. PainReform has a 12-month low of $1.78 and a 12-month high of $26.41. The firm has a 50 day simple moving average of $2.01 and a 200-day simple moving average of $2.48.

Institutional Investors Weigh In On PainReform

A hedge fund recently bought a new stake in PainReform stock. Armistice Capital LLC acquired a new stake in shares of PainReform Ltd. (NASDAQ:PRFX) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 170,000 shares of the company’s stock, valued at approximately $468,000. Armistice Capital LLC owned about 10.90% of PainReform as of its most recent filing with the Securities and Exchange Commission. 37.28% of the stock is currently owned by institutional investors.

About PainReform

PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. The company engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia.